Recent Asset Investment Clearwater Paper has invested $23 million in a new facial tissue converting line at its Shelby, North Carolina facility, indicating ongoing capacity expansion and a focus on high-quality tissue manufacturing, which presents opportunities for suppliers of tissue converting equipment and related automation solutions.

Divestiture Moves The sale of its tissue division to Sofidel for over $1 billion suggests a strategic shift, potentially freeing up resources for targeted growth elsewhere or creating new opportunities in adjacent markets such as specialty paper products or raw material supply chains.

Financial Focus With revenues ranging between $10 million and $25 million, Clearwater Paper is a mid-sized enterprise that may be open to solutions that enhance operational efficiency, cost management, or product innovation to accelerate growth within the tissue and paper product sectors.

Industry Engagement Active participation in materials and agricultural conferences indicates a strategic effort to strengthen market relationships and explore new supply chain collaborations, offering sales opportunities in raw materials, sustainable packaging, and advanced manufacturing technology.

Sustainability & Innovation Investments in new manufacturing lines and strategic conferences emphasize a focus on innovation and sustainability, presenting potential for offering eco-friendly solutions, recycled materials, or process automation to support Clearwater Paper's evolving product portfolio.